BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 19158423)

  • 1. Integrating gene expression and phenotypic information to analyze Alzheimer's disease.
    Ray M; Zhang W
    J Alzheimers Dis; 2009; 16(1):73-84. PubMed ID: 19158423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease.
    Wu ZL; Ciallella JR; Flood DG; O'Kane TM; Bozyczko-Coyne D; Savage MJ
    Neurobiol Aging; 2006 Mar; 27(3):377-86. PubMed ID: 15927307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression as peripheral biomarkers for sporadic Alzheimer's disease.
    Grünblatt E; Bartl J; Zehetmayer S; Ringel TM; Bauer P; Riederer P; Jacob CP
    J Alzheimers Dis; 2009; 16(3):627-34. PubMed ID: 19276557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses.
    Blalock EM; Geddes JW; Chen KC; Porter NM; Markesbery WR; Landfield PW
    Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2173-8. PubMed ID: 14769913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models.
    Reddy PH; McWeeney S
    Neurobiol Aging; 2006 Aug; 27(8):1060-77. PubMed ID: 16157420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clustering expressed genes on the basis of their association with a quantitative phenotype.
    Jia Z; Xu S
    Genet Res; 2005 Dec; 86(3):193-207. PubMed ID: 16454859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixture classification model based on clinical markers for breast cancer prognosis.
    Zeng T; Liu J
    Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling.
    Colangelo V; Schurr J; Ball MJ; Pelaez RP; Bazan NG; Lukiw WJ
    J Neurosci Res; 2002 Nov; 70(3):462-73. PubMed ID: 12391607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multigenerational pedigree of late-onset Alzheimer's disease implies new genetic causes.
    Jimenez-Escrig A; Gomez-Tortosa E; Baron M; Rabano A; Arcos-Burgos M; Palacios LG; Yusta A; Anta P; Perez I; Hierro M; Munoz DG; Barquero S
    Brain; 2005 Jul; 128(Pt 7):1707-15. PubMed ID: 15843424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential neuropsychological patterns of frontal variant frontotemporal dementia and Alzheimer's disease in a study of diagnostic concordance.
    Giovagnoli AR; Erbetta A; Reati F; Bugiani O
    Neuropsychologia; 2008 Apr; 46(5):1495-504. PubMed ID: 18262206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel subtractive transcription-based amplification of mRNA (STAR) method and its application in search of rare and differentially expressed genes in AD brains.
    Liu QY; Sooknanan RR; Malek LT; Ribecco-Lutkiewicz M; Lei JX; Shen H; Lach B; Walker PR; Martin J; Sikorska M
    BMC Genomics; 2006 Nov; 7():286. PubMed ID: 17090317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of misdiagnosis in input data on the identification of differential expression genes in incipient Alzheimer patients.
    Joseph S; Robbins K; Zhang W; Rekaya R
    In Silico Biol; 2008; 8(5-6):545-54. PubMed ID: 19374137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomics and phenotypic profiles in dementia: implications for pharmacological treatment.
    Cacabelos R; Fernández-Novoa L; Corzo L; Pichel V; Lombardi V; Kubota Y
    Methods Find Exp Clin Pharmacol; 2004; 26(6):421-44. PubMed ID: 15349138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline.
    Suh GH; Ju YS; Yeon BK; Shah A
    Int J Geriatr Psychiatry; 2004 Sep; 19(9):817-24. PubMed ID: 15352138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mini-mental state examination is sensitive to brain atrophy in Alzheimer's disease.
    Fjell AM; Amlien IK; Westlye LT; Walhovd KB
    Dement Geriatr Cogn Disord; 2009; 28(3):252-8. PubMed ID: 19786777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuropsychiatric inventory scores change across the mini mental state examination ranges in patients with Alzheimer's disease: a multicenter study in Turkey.
    Yener GG;
    Cogn Behav Neurol; 2009 Dec; 22(4):264-9. PubMed ID: 19996880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons.
    Ginsberg SD; Hemby SE; Lee VM; Eberwine JH; Trojanowski JQ
    Ann Neurol; 2000 Jul; 48(1):77-87. PubMed ID: 10894219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting and analyzing differentially activated pathways in brain regions of Alzheimer's disease patients.
    Liu ZP; Wang Y; Zhang XS; Xia W; Chen L
    Mol Biosyst; 2011 May; 7(5):1441-52. PubMed ID: 21336338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippocampus neuronal metabolic gene expression outperforms whole tissue data in accurately predicting Alzheimer's disease progression.
    Stempler S; Waldman YY; Wolf L; Ruppin E
    Neurobiol Aging; 2012 Sep; 33(9):2230.e13-2230.e21. PubMed ID: 22560482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.